AbbVie Inc. – Biasly

AbbVie Inc. Follow

3 Fantastic Dividend Stocks to Buy Sooner Rather Than Later | The Motley Fool

Johnson & Johnson

3 Fantastic Dividend Stocks to Buy Sooner Rather Than Later | The Motley Fool

The Motley Fool
Dec 01, 2024

Center

European Commission Approves AbbVie's ELAHERE For Platinum-Resistant Ovarian Cancer Treatment

Serous fluid

European Commission Approves AbbVie's ELAHERE For Platinum-Resistant Ovarian Cancer Treatment

FinanzNachrichten.de
Nov 18, 2024

Center

The Smartest Dividend Stocks to Buy With $250 Right Now | The Motley Fool

Share price

The Smartest Dividend Stocks to Buy With $250 Right Now | The Motley Fool

The Motley Fool
Jul 08, 2024

Somewhat Conservative

The trick America's biggest drug companies are using to screw over taxpayers

Pharmaceutical industry

The trick America's biggest drug companies are using to screw over taxpayers

Business Insider
Aug 03, 2023

Center

Buy AbbVie Stock. The Pharma Giant Is Still Worth Owning Even as Humira Fades.

Adalimumab

Buy AbbVie Stock. The Pharma Giant Is Still Worth Owning Even as Humira Fades.

MarketWatch
Dec 03, 2022

Center

Here's our September rapid-fire update on all 33 stocks in Cramer's Charitable Trust portfolio

AbbVie Inc.

Here's our September rapid-fire update on all 33 stocks in Cramer's Charitable Trust portfolio

CNBC
Sep 16, 2022

Center